Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

168 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.
Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Barragán-Rodríguez L, et al. Magnes Res. 2008 Dec;21(4):218-23. Magnes Res. 2008. PMID: 19271419 Clinical Trial.
Increased levels of C-reactive protein in noncontrolled type II diabetic subjects.
Rodríguez-Morán M, Guerrero-Romero F. Rodríguez-Morán M, et al. J Diabetes Complications. 1999 Jul-Aug;13(4):211-5. doi: 10.1016/s1056-8727(99)00047-1. J Diabetes Complications. 1999. PMID: 10616861
Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
Guerrero-Romero F, Rodríguez-Morán M. Guerrero-Romero F, et al. J Diabetes Complications. 2000 Sep-Oct;14(5):272-6. doi: 10.1016/s1056-8727(00)00127-6. J Diabetes Complications. 2000. PMID: 11113690
Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes.
Rodríguez-Morán M, Guerrero-Romero F. Rodríguez-Morán M, et al. Arch Med Res. 2001 Jul-Aug;32(4):300-3. doi: 10.1016/s0188-4409(01)00298-3. Arch Med Res. 2001. PMID: 11440788
Low serum magnesium levels and metabolic syndrome.
Guerrero-Romero F, Rodríguez-Morán M. Guerrero-Romero F, et al. Acta Diabetol. 2002 Dec;39(4):209-13. doi: 10.1007/s005920200036. Acta Diabetol. 2002. PMID: 12486495
Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.
Guerrero-Romero F, Rodríguez-Morán M. Guerrero-Romero F, et al. Diabetes Metab. 2003 Feb;29(1):65-71. doi: 10.1016/s1262-3636(07)70009-5. Diabetes Metab. 2003. PMID: 12629450
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Rodríguez-Morán M, Guerrero-Romero F. Rodríguez-Morán M, et al. Diabetes Care. 2003 Apr;26(4):1147-52. doi: 10.2337/diacare.26.4.1147. Diabetes Care. 2003. PMID: 12663588 Clinical Trial.
Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control.
Rodríguez-Morán M, Guerrero-Romero F. Rodríguez-Morán M, et al. J Endocrinol Invest. 2003 Mar;26(3):216-21. doi: 10.1007/BF03345160. J Endocrinol Invest. 2003. PMID: 12809171 Clinical Trial.
168 results
Jump to page
Feedback